| abstract |
ABSTRACT OF THF DISCLOSURE A process for the preparation of novel antitumor an-thracycline glycosides by condensing daunomycinone wlth 2,3,4,6-tetradeoxy-4-C-methylene-3-trifluoroacetamido-L-threo-hexopyranosyl chloride; 2,3,4,6-tetradeoxy-4-C-methylene-3-trifluoroacetamido-L-arabino-hexopyranosyl chloride or 2,3,6-trideoxy-4-C-trifluoro-acetamideomethyl-3-trifluoroacetamido-3-0-trifluoroacetyl-L-lyxo-hexopyranosyl chloride. |